Abstract
Osteoarthritis (OA) is a progressive degeneration of articular cartilage with involvement of synovial membrane, and subchondral bone. Current treatment approaches have focused on controlling the OA symptoms, pain, and inflammation. Recently, cell-based therapies, including the application of stem cells such as mesenchymal stem cells (MSCs), have been introduced for restoration of the articular cartilage. Despite promising outcomes, there are some limitations in the application of MSCs for OA treatment. It has been demonstrated that the regenerative potential of stem cells is related to the production of paracrine factors. Extracellular vehicles (EVs), the main component of cell secretome, are membrane-bounded structures that deliver biologically active agents. The delivery of molecules (e.g., nucleic acids, proteins, and lipids) leads to cell-to-cell communication and the alteration of cell functions. In this review, general characteristics of EVs, as well as their potential mechanisms in the prevention and treatment of OA were considered. Based on in vitro and in vivo studies, EVs have shown to contribute to cartilage regeneration via suppression of degenerative factors and regulation of chondrocyte function in the synthesis of extracellular matrix components. Also, they inhibit the progression of OA or protect the cartilage from degradation via their impact on inflammatory cytokines. The different signaling pathways of EVs against the pathologic features of OA were summarized in this review. According to the results obtained from several investigations, more investigations should be design to prove the safety and effectiveness of EVs in the treatment and prevention of OA progression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abramson SB, Attur M, Amin AR, Clancy R (2001) Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3:535–541
Alizamir T, Akbari M, Mokhtari T, Hassanzadeh G (2017) Associated functional motor recovery induced by Intracerebroventricular (ICV) microinjection of Wharton’s jelly mesenchymal stem cells following brain ischemia/reperfusion injury in rat: decreased dark neurons and Bax gene expression in the cerebral corte. J Contemp Med Sci 3:12
Anderson HC, Mulhall D, Garimella R (2010) Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Lab Invest 90:1549–1557. https://doi.org/10.1038/labinvest.2010.152
Ansari MY, Ahmad N, Haqqi TM (2020) Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols. Biomed Pharmacother 129:110452. https://doi.org/10.1016/j.biopha.2020.110452
Arab L et al (2020) Human embryonic derived neural progenitor cells improves neurological scores following brain ischemia/reperfusion: modulation of blood and brain tissue microRNA-210. J Contemp Med Sci 1594:93
Arslan E, Guler MO, Tekinay AB (2016) Glycosaminoglycan-mimetic signals direct the osteo/chondrogenic differentiation of mesenchymal stem cells in a three-dimensional peptide nanofiber extracellular. Matrix Mimetic Environ Biomacromol 17:1280–1291. https://doi.org/10.1021/acs.biomac.5b01637
Bagherifard A et al (2015) Platelet-rich plasma injection for symptomatic knee osteoarthritis. J Res Orthop Sci 2:0–0
Bannuru RR, Vaysbrot EE, Sullivan MC, McAlindon TE (2014) Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis. In: Seminars in arthritis and rheumatism, vol 5. Elsevier, pp 593–599
Ben-David U, Mayshar Y, Benvenisty N (2011) Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 9:97–102. https://doi.org/10.1016/j.stem.2011.06.013
Blagojevic M, Jinks C, Jeffery A, Jordan KP (2010) Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthr Cartil 18:24–33. https://doi.org/10.1016/j.joca.2009.08.010
Börger V, Bremer M, Ferrer-Tur R, Gockeln L, Stambouli O, Becic A, Giebel B (2017) Mesenchymal stem/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents. Int J Mol Sci 18:1450
Casado-Díaz A, Quesada-Gómez JM, Dorado G (2020) Extracellular vesicles derived from mesenchymal stem cells (MSC) in regenerative medicine: applications in skin wound healing. Front Bioeng Biotechnol 8:146
Chahal J et al (2019) Bone marrow mesenchymal stromal cell treatment in patients with osteoarthritis results in overall improvement in pain and symptoms and reduces synovial inflammation. Stem Cells Transl Med 8:746–757
Chen T-M, Chen Y-H, Sun HS, Tsai S-J (2019) Fibroblast growth factors: Potential novel targets for regenerative therapy of osteoarthritis . Chin J Physiol 62:2
Coggon D, Reading I, Croft P, McLaren M, Barrett D, Cooper C (2001) Knee osteoarthritis and obesity. Int J Obes 25:622–627
Colombo M, Raposo G, Théry C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–289. https://doi.org/10.1146/annurev-cellbio-101512-122326
Cooper C et al (2019) Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: what does the literature say? Drugs Aging 36:15–24
Cosenza S, Ruiz M, Toupet K, Jorgensen C, Noël D (2017) Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep 7:16214. https://doi.org/10.1038/s41598-017-15376-8
Courties A, Gualillo O, Berenbaum F, Sellam J (2015) Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthr Cartil 23:1955–1965
Doyle LM, Wang MZ (2019) Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome. Isol Analy Cells 8:727. https://doi.org/10.3390/cells8070727
Fafián-Labora J et al (2017) Effect of age on pro-inflammatory miRNAs contained in mesenchymal stem cell-derived extracellular vesicles. Sci Rep 7:43923. https://doi.org/10.1038/srep43923
Felson DT (2013) Osteoarthritis as a disease of mechanics. Osteoarthr Cartil 21:10–15
Fu Y, Karbaat L, Wu L, Leijten J, Both SK, Karperien M (2017) Trophic effects of mesenchymal stem cells in tissue regeneration . Tissue Eng Part B Rev 23:515–528. https://doi.org/10.1089/ten.TEB.2016.0365
Furuta T et al (2016) Mesenchymal stem cell-derived exosomes promote fracture healing in a mouse model stem. Cells Transl Med 5:1620–1630. https://doi.org/10.5966/sctm.2015-0285
García-Romero N et al (2017) DNA sequences within glioma-derived extracellular vesicles can cross the intact blood–brain barrier and be detected in peripheral blood. of patients Oncotarget 8:1416–1428. https://doi.org/10.18632/oncotarget.13635
Gholamrezanezhad A et al (2011) In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol 38:961–967. https://doi.org/10.1016/j.nucmedbio.2011.03.008
Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA. activity Nature cell biology 11:1143–1149
Goldring MB (1999) The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 40:1–11. https://doi.org/10.3109/03008209909005273
Goldring MB, Berenbaum F (2015) Emerging targets in osteoarthritis therapy. Curr Opin Pharmacol 22:51–63. https://doi.org/10.1016/j.coph.2015.03.004
Goldring MB et al (2011) Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater 21:202–220. https://doi.org/10.22203/ecm.v021a16
Gowen A, Shahjin F, Chand S, Odegaard KE, Yelamanchili SV (2020) Mesenchymal stem cell-derived extracellular vesicles: challenges in clinical applications. Front Cell Dev Biol 8:149. https://doi.org/10.3389/fcell.2020.00149
Harirforoosh S, Asghar W, Jamali F (2013) Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci 16:821–847
Heinegård D, Saxne T (2011) The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol 7:50–56. https://doi.org/10.1038/nrrheum.2010.198
Henrotin Y, Kurz B, Aigner T (2005) Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthr Cartil 13:643–654. https://doi.org/10.1016/j.joca.2005.04.002
Herberts CA, Kwa MS, Hermsen HP (2011) Risk factors in the development of stem cell therapy. J Transl Med 9:1–14
Holm MM, Kaiser J, Schwab ME (2018) Extracellular vesicles: multimodal envoys in neural maintenance and repair. Trends Neurosci 41:360–372
Huang J, Zhao L, Chen D (2018) Growth factor signalling in osteoarthritis. Growth Factors 36:187–195. https://doi.org/10.1080/08977194.2018.1548444
Ijaz S, Mohammed I, Gholaminejhad M, Mokhtari T, Akbari M, Hassanzadeh G (2020) Modulating pro-inflammatory cytokines, tissue damage magnitude, and motor deficit in spinal cord injury with subventricular zone-derived extracellular vesicles. J Mol Neurosci 70:458–466
Im HJ et al (2010) Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum 62:2995–3005. https://doi.org/10.1002/art.27608
Inoue H et al (2008) High levels of serum IL-18 promote cartilage loss through suppression of aggrecan synthesis. Bone 42:1102–1110. https://doi.org/10.1016/j.bone.2008.01.031
Jafari D, Malih S, Eslami SS, Jafari R, Darzi L, Tarighi P, Samadikuchaksaraei A (2019) The relationship between molecular content of mesenchymal stem cells derived exosomes and their potentials: opening the way for exosomes based therapeutics. Biochimie 165:76–89
Jiang YZ, Zhang SF, Qi YY, Wang LL, Ouyang HW (2011) Cell transplantation for articular cartilage defects: principles of past, present, and future practice. Cell Transpl 20:593–607
Kazemi SM, Besheli LD, Eajazi A, Sajadi MRM, Okhovatpoor MA, Zanganeh RF, Minaei R (2011) Pseudo-patella baja after total knee arthroplasty. Med Sci Monitor 17:CR292
Kern S, Eichler H, Stoeve J, Klüter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue. Stem Cells 24:1294–1301
Keshtkar S, Azarpira N, Ghahremani MH (2018) Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther 9:63
Khatab S et al (2018) Mesenchymal stem cell secretome reduces pain and prevents cartilage damage in a murine osteoarthritis model. Eur Cells Mater 36:218–230
Kim J, Xu M, Xo R, Mates A, Wilson GL, Pearsall AW, Grishko V (2010) Mitochondrial DNA damage is involved in apoptosis caused by pro-inflammatory cytokines in human OA chondrocytes. Osteoarthr Cartil 18:424–432. https://doi.org/10.1016/j.joca.2009.09.008
Kolhe R et al (2017) Gender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritis. Sci Rep 7:2029. https://doi.org/10.1038/s41598-017-01905-y
Kolhe R et al (2020) Sex-specific differences in extracellular vesicle protein cargo in synovial fluid of patients with osteoarthritis. Life 10:337
Lai RC et al (2010a) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4:214–222. https://doi.org/10.1016/j.scr.2009.12.003
Lai RC et al (2010b) Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. J Mol Cell Cardiol 48:1215–1224. https://doi.org/10.1016/j.yjmcc.2009.12.021
Lener T et al (2015) Applying extracellular vesicles based therapeutics in clinical trials: an ISEV position paper. J Extracell Vesicles 4:30087
Lepetsos P, Papavassiliou AG (2016) ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta 1862:576–591. https://doi.org/10.1016/j.bbadis.2016.01.003
Li J, Dong S (2016) The signaling pathways involved in chondrocyte differentiation and hypertrophic differentiation. Stem Cells Int 2016:2470351–2470351. https://doi.org/10.1155/2016/2470351
Lister BJ, Poland M, DeLapp RE (1993) Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. Am J Med 95:S2–S9
Liu Y, Zou R, Wang Z, Wen C, Zhang F, Lin F (2018) Exosomal KLF3-AS1 from hMSCs promoted cartilage repair and chondrocyte proliferation in osteoarthritis. Biochem J 475:3629–3638
Mahshid B et al (2018) Lipid peroxidation and its role in the expression of NLRP1a and NLRP3 genes in testicular tissue of male rats: a model of spinal cord injury
Mancuso P, Raman S, Glynn A, Barry F, Murphy JM (2019) Mesenchymal stem cell therapy for osteoarthritis. The critical role of the cell secretome. Front Bioeng Biotechnol 7:9. https://doi.org/10.3389/fbioe.2019.00009
Matas J et al (2019) Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I/II trial . Stem Cells Transl Med 8:215–224
Miyaki S, Asahara H (2012) Macro view of microRNA function in osteoarthritis. Nat Rev Rheumatol 8:543–552. https://doi.org/10.1038/nrrheum.2012.128
Miyaki S, Lotz MK (2018) Extracellular vesicles in cartilage homeostasis and osteoarthritis. Curr Opin Rheumatol 30:129–135. https://doi.org/10.1097/BOR.0000000000000454
Miyaki S et al (2010) MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 24:1173–1185. https://doi.org/10.1101/gad.1915510
Mohammadinejad R et al (2020) Nanotechnological strategies for osteoarthritis diagnosis, monitoring, clinical management, and regenerative medicine: recent advances and future opportunities. Curr Rheumatol Rep 22:12. https://doi.org/10.1007/s11926-020-0884-z
Mohammed I et al (2020) Subventricular zone-derived extracellular vesicles promote functional recovery in rat model of spinal cord injury by inhibition of NLRP3 inflammasome complex formation. Metab Brain Dis 35:809
Morales-Ivorra I, Romera-Baures M, Roman-Viñas B, Serra-Majem L (2018) Osteoarthritis and the Mediterranean diet: a systematic review. Nutrients 10:1030
Mustonen A-M, Nieminen P (2021) Extracellular vesicles and their potential significance in the pathogenesis and treatment of osteoarthritis. Pharmaceuticals 14:315
Nakamura Y et al (2015) Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration. FEBS Lett 589:1257–1265. https://doi.org/10.1016/j.febslet.2015.03.031
Natasha G, Gundogan B, Tan A, Farhatnia Y, Wu W, Rajadas J, Seifalian AM (2014) Exosomes as immunotheranostic nanoparticles. Clin Ther 36:820–829. https://doi.org/10.1016/j.clinthera.2014.04.019
Nikmehr B et al (2017) The correlation of gene expression of inflammasome indicators and impaired fertility in rat model of spinal cord injury: a time course study. Urol J 14:5057–5063
Noori L, Arabzadeh S, Mohamadi Y, Mojaverrostami S, Mokhtari T, Akbari M, Hassanzadeh G (2020) Intrathecal administration of the extracellular vesicles derived from human Wharton’s jelly stem cells inhibit inflammation and attenuate the activity of inflammasome complexes after spinal cord injury in rats. Neurosci Res 170:87
Pal B, Endisha H, Zhang Y, Kapoor M (2015) mTOR: a potential therapeutic target in osteoarthritis? Drugs R D 15:27–36
Palazzo C, Nguyen C, Lefevre-Colau M-M, Rannou F, Poiraudeau S (2016) Risk factors and burden of osteoarthritis. Ann Phys Rehabil Med 59:134–138. https://doi.org/10.1016/j.rehab.2016.01.006
Pas HI, Winters M, Haisma HJ, Koenis MJ, Tol JL, Moen MH (2017) Stem cell injections in knee osteoarthritis: a systematic review of the literature. Br J Sports Med 51:1125–1133
Pham T, Cornea A, Jenkins A, Blick KE, Scofield RH (2007) Oral glucosamine in doses used to treat osteoarthritis worsens insulin resistance. Am J Med Sci 333:333–339
Phinney DG, Pittenger MF (2017) Concise review: MSC-derived exosomes for cell‐free therapy. Stem Cells 35:851–858
Qi H, Liu DP, Xiao DW, Tian DC, Su YW, Jin SF (2019) Exosomes derived from mesenchymal stem cells inhibit mitochondrial dysfunction-induced apoptosis of chondrocytes via p38, ERK, and Akt pathways . In Vitro Cell Dev Biol Anim 55:203–210. https://doi.org/10.1007/s11626-019-00330-x
Raeissadat SA, Gharooee Ahangar A, Rayegani SM, Minator Sajjadi M, Ebrahimpour A, Yavari P (2020) Platelet-rich plasma-derived growth factor vs hyaluronic acid injection in the individuals with knee osteoarthritis: a one year randomized clinical trial. J Pain Res 13:1699–1711. https://doi.org/10.2147/JPR.S210715
Ragni E et al (2019) miR-22-5p and miR-29a-5p are reliable reference genes for analyzing extracellular vesicle-associated miRNAs in adipose-derived mesenchymal stem cells and are stable under inflammatory priming mimicking osteoarthritis condition. Stem Cell Rev Rep 15:743–754. https://doi.org/10.1007/s12015-019-09899-y
Ramasubramanian L, Kumar P, Wang A (2020) Engineering extracellular vesicles as nanotherapeutics for regenerative medicine. Biomolecules 10:48
Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R, Lindstrom TM, Sokolove J (2016) Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol 12:580–592. https://doi.org/10.1038/nrrheum.2016.136
Sajjadi MM, Keyhani S, Kazemi SM, Hanafizadeh B, Ebrahimpour A, Banasiri M (2019) Patient satisfaction following total knee arthroplasty: comparison of short-term results in rheumatoid arthritis and osteoarthritis. Arch Bone Joint Surg 7:61
Scotti C et al (2016) Cartilage repair in the inflamed joint: considerations for biological augmentation toward tissue regeneration. Tissue Eng Part B 22:149–159
Shah SS, Mithoefer K (2020) Current applications of growth factors for knee cartilage repair and osteoarthritis treatment. Curr Rev Musculoskel Med 13:641
Smith SR, Deshpande BR, Collins JE, Katz JN, Losina E (2016) Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review. Osteoarthr Cartil 24:962–972. https://doi.org/10.1016/j.joca.2016.01.135
Sokolove J, Lepus CM (2013) Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Therap Adv Musculoskelet Dis 5:77–94
Spiller KL, Anfang RR, Spiller KJ, Ng J, Nakazawa KR, Daulton JW, Vunjak-Novakovic G (2014) The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials 35:4477–4488
Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200:448–464
Subra C, Laulagnier K, Perret B, Record M (2007) Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 89:205–212
Sun AR, Friis T, Sekar S, Crawford R, Xiao Y, Prasadam I (2016) Is synovial macrophage activation the inflammatory link between obesity and osteoarthritis? Curr Rheumatol Rep 18:1–14
Sun X, Meng H, Wan W, Xie M, Wen C (2019) Application potential of stem/progenitor cell-derived extracellular vesicles in renal diseases. Stem Cell Res Ther 10:1–9
Tao SC, Yuan T, Zhang YL, Yin WJ, Guo SC, Zhang CQ (2017) Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model . Theranostics 7:180–195. https://doi.org/10.7150/thno.17133
Timmers L et al (2008) Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 1:129–137
Tkach M, Théry C (2016) Communication by extracellular vesicles: where we are and where we need to go. Cell 164:1226–1232. https://doi.org/10.1016/j.cell.2016.01.043
Tofiño-Vian M, Guillén MI, Pérez D, Caz MD, Castejón MA, Alcaraz MJ (2017) Extracellular vesicles from adipose-derived mesenchymal stem cells downregulate senescence features in osteoarthritic osteoblasts. Oxid Med Cell Longev 2017:7197598. https://doi.org/10.1155/2017/7197598
Tofiño-Vian M, Guillén MI, Pérez D, Caz MD, Silvestre A, Alcaraz MJ (2018) Microvesicles from human adipose tissue-derived mesenchymal stem cells as a new protective strategy in osteoarthritic chondrocytes. Cell Physiol Biochem 47:11–25. https://doi.org/10.1159/000489739
Toh WS, Foldager CB, Pei M, Hui JH (2014) Advances in mesenchymal stem cell-based strategies for cartilage repair and regeneration Stem. Cell Rev Rep 10:686–696. https://doi.org/10.1007/s12015-014-9526-z
Toh WS, Lai RC, Hui JHP, Lim SK (2017) MSC exosome as a cell-free MSC therapy for cartilage regeneration: implications for osteoarthritis treatment Semin. Cell Dev Biol 67:56–64. https://doi.org/10.1016/j.semcdb.2016.11.008
Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654–659. https://doi.org/10.1038/ncb1596
van den Berg WB (1999) The role of cytokines and growth factors in cartilage destruction in osteoarthritis and rheumatoid arthritis. Zeitschrift für Rheumatologie 58:136–141. https://doi.org/10.1007/s003930050163
Verma P, Dalal K (2011) ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem 112:3507–3514. https://doi.org/10.1002/jcb.23298
Vincent TL (2019) IL-1 in osteoarthritis: time for a critical review of the literature F1000Res 8:F1000 Faculty Rev-1934 https://doi.org/10.12688/f1000research.18831.1
Wang J, Xia J, Huang R, Hu Y, Fan J, Shu Q, Xu J (2020) Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage polarization. Stem Cell Res Therapy 11:424. https://doi.org/10.1186/s13287-020-01937-8
Wang J, Xia J, Huang R, Hu Y, Fan J, Shu Q, Xu J (2020) Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage polarization. Stem Cell Res Ther 11:1–12
Withrow J, Murphy C, Liu Y, Hunter M, Fulzele S, Hamrick MW (2016) Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis. Arthritis Res Therapy 18:286. https://doi.org/10.1186/s13075-016-1178-8
Witwer KW et al (2019) Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles 8:1609206
Wojdasiewicz P, Poniatowski ŁA, Szukiewicz D (2014) The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediat Inflamm 2014:561459. https://doi.org/10.1155/2014/561459
Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13:269–288. https://doi.org/10.1111/j.1365-2141.1967.tb08741.x
Worthington EN, Hagood JS (2020) Therapeutic use of extracellular vesicles for acute and chronic lung disease. Int J Mol Sci 21:2318
Wu J et al (2019) miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials 206:87–100. https://doi.org/10.1016/j.biomaterials.2019.03.022
Wu Y et al (2015) Mesenchymal stem cells suppress fibroblast proliferation and reduce skin fibrosis through a TGF-β3-dependent activation. Int J Low Extrem Wounds 14:50–62. https://doi.org/10.1177/1534734614568373
Wu X, Wang Y, Xiao Y, Crawford R, Mao X, Prasadam I (2020) Extracellular vesicles: potential role in osteoarthritis regenerative medicine. J Orthop Transl 21:73–80. https://doi.org/10.1016/j.jot.2019.10.012
Wyles CC, Houdek MT, Behfar A, Sierra RJ (2015) Mesenchymal stem cell therapy for osteoarthritis: current perspectives. Stem Cells Cloning 8:117–124. https://doi.org/10.2147/sccaa.S68073
Xie Y, Zhou W, Zhong Z, Zhao Z, Yu H, Huang Y, Zhang P (2020) Metabolic syndrome, hypertension, and hyperglycemia were positively associated with knee osteoarthritis, while dyslipidemia showed no association with knee osteoarthritis. Clin Rheumatol 1–14
Yang Y, Wang H, Kouadir M, Song H, Shi F (2019) Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis 10:128. https://doi.org/10.1038/s41419-019-1413-8
Yeo RW, Lai RC, Zhang B, Tan SS, Yin Y, Teh BJ, Lim SK (2013) Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev 65:336–341. https://doi.org/10.1016/j.addr.2012.07.001
Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T (2011) Association of knee osteoarthritis with the accumulation of metabolic risk factors such as overweight, hypertension, dyslipidemia, and impaired glucose tolerance in Japanese men and women: the ROAD study. J Rheumatol 38:921–930
Yubo M, Yanyan L, Li L, Tao S, Bo L, Lin C (2017) Clinical efficacy and safety of mesenchymal stem cell transplantation for osteoarthritis treatment: A meta-analysis. PLoS ONE 12:e0175449. https://doi.org/10.1371/journal.pone.0175449
Yusuf E (2016) Pharmacologic and non-pharmacologic treatment of osteoarthritis. Curr Treat Options Rheumatol 2:111–125. https://doi.org/10.1007/s40674-016-0042-y
Zhang Y, Jordan JM (2010) Epidemiology of osteoarthritis. Clin Geriatr Med 26:355–369. https://doi.org/10.1016/j.cger.2010.03.001
Zhang S, Chu WC, Lai RC, Lim SK, Hui JH, Toh WS (2016) Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthr Cartil 24:2135–2140. https://doi.org/10.1016/j.joca.2016.06.022
Zhang S, Teo KYW, Chuah SJ, Lai RC, Lim SK, Toh WS (2019) MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis. Biomaterials 200:35–47. https://doi.org/10.1016/j.biomaterials.2019.02.006
Zhu Y et al (2017) Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis Stem. Cell Res Ther 8:64. https://doi.org/10.1186/s13287-017-0510-9
Zhuang X et al (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19:1769–1779. https://doi.org/10.1038/mt.2011.164
Funding
No funding to declare.
Author information
Authors and Affiliations
Contributions
SJS1 and AM conceived of the presented idea. SJS1, SMH, MMS and SJS2 equally participated in drafting the article. MMS and AM participated in revising it critically for important intellectual content. All authors gave final approval of the version to be submitted and any revised version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Consent to publish
N/A.
Informed consent
N/A.
Research involving human participants and/or animals
N/A.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jousheghan, S.S., Sajjadi, M.M., Jousheghan, S.S. et al. Extracellular vesicles as novel approaches for the treatment of osteoarthritis: a narrative review on potential mechanisms. J Mol Histol 52, 879–891 (2021). https://doi.org/10.1007/s10735-021-10017-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-021-10017-x